Actively Recruiting
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2024-04-05
200
Participants Needed
1
Research Sites
678 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate: The radiographic progression-free survival (rPFS) of metastatic hormone-sensitive prostate cancer (mHSPC) patients treated with androgen deprivation therapy (ADT) + second-generation antiandrogens±chemotherapy combined with cytoreductive prostatectomy (CRP)
CONDITIONS
Official Title
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male aged 18 to 75 years
- Histologically confirmed prostate adenocarcinoma
- Evidence of metastasis confirmed by MRI, CT scan, bone scan, or histology
- Clinical stage M1a, M1b, or M1c
- No prior local treatment for prostate cancer
- Surgeon believes prostate can be removed
You will not qualify if you...
- Surgeon believes disease is unresectable
- Life expectancy less than 2 years
- Active spinal cord compression
- History of prior local treatment for prostate cancer
- Difficulty swallowing, chronic diarrhea, intestinal obstruction, or other factors affecting drug intake and absorption
- Refusal to sign informed consent
- Investigator believes individual is not suitable for inclusion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210029
Actively Recruiting
Research Team
L
Lixin Hua, M.D.
CONTACT
S
Shangqian Wang, M.D.,PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here